Key result
Myocardial fibrosis assessment advances but needs further research to establish prognostic value and anti-fibrosis therapies.
Why the study?
Myocardial fibrosis is crucial in heart failure, but much work is still needed to fully understand its features and clinical role.
This review highlights the importance of myocardial fibrosis assessment and quantification in heart failure and emphasizes the need for further research into its prognostic role and anti-fibrotic therapies.
No takes yet. Share an insight, caveat, or question.
MF assessment and therapies in HF remain incompletely defined; leaves open standardization and targeted interventions for prospective trials.
Poddi et al. (2025) conducted a review in Myocardial fibrosis and heart failure (n=40). Myocardial fibrosis assessment and anti-fibrosis targets was evaluated. Myocardial fibrosis assessment and quantification have advanced significantly, though further research is needed to strengthen its role as a prognostic factor and develop anti-fibrosis treatments.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: